Cancer Drug Design and Discovery
- 1st Edition - November 14, 2007
- Imprint: Academic Press
- Editor: Stephen Neidle
- Language: English
- eBook ISBN:9 7 8 - 0 - 0 8 - 0 5 5 4 9 5 - 2
The ultimate source of information on the design of new anticancer agents, emphasizing small molecules, this newest work covers recent notable successes resulting from the human… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteThe ultimate source of information on the design of new anticancer agents, emphasizing small molecules, this newest work covers recent notable successes resulting from the human genome and cancer genomics projects. These advances have provided information on targets involved in specific cancers that are leading to effective medicines for at least some of the common solid tumors. Unique sections explain the basic underlying principles of cancer drug development and provide a practical introduction to modern methods of drug design. Appealing to a broad audience, this is an excellent reference for translational researchers interested in cancer biology and medicine as well as students in pharmacy, pharmacology, or medicinal and biological chemistry and clinicians taking oncology options.
* Covers both currently available drugs as well as those under development
* Provides a clinical perspective on trials of new anticancer agents
* Presents drug discovery examples through the use of case histories
* Provides a clinical perspective on trials of new anticancer agents
* Presents drug discovery examples through the use of case histories
Translational researchers interested in cancer biology and medicine. Students in pharmacy, pharmacology, or medicinal and biological chemistry, as well as clinicians taking oncology options.
- Edition: 1
- Published: November 14, 2007
- No. of pages (eBook): 496
- Imprint: Academic Press
- Language: English
- eBook ISBN: 9780080554952
SN
Stephen Neidle
Stephen Neidle is an Emeritus Professor of Chemical Biology at University College London, where he has also been the Director of Research in the School of Pharmacy. He has published over 500 primary papers and reviews and is a principal inventor on 14 patent filings. He has also written and edited several books on nucleic acids and anti-cancer drugs.
Affiliations and expertise
Emeritus Professor of Chemical Biology, The School of Pharmacy, University College London, UKRead Cancer Drug Design and Discovery on ScienceDirect